SGLT2 Inhibitors Like Jardiance for Heart Failure Without Diabetes

SGLT2 Inhibitors Like Jardiance for Heart Failure Without Diabetes

Heart failure (HF) is a chronic, progressive condition where the heart cannot pump blood effectively, leading to symptoms like shortness of breath, fatigue, and fluid retention. Historically, treatment focused on medications such as ACE inhibitors, ARBs, beta-blockers, and diuretics. But in recent years, SGLT2 inhibitors, originally developed for type 2 diabetes, have emerged as a game-changing therapy, even for people without diabetes.

How SGLT2 Inhibitors Work in Heart Failure

SGLT2 inhibitors (sodium-glucose co-transporter 2 inhibitors) include empagliflozin (Jardiance) and dapagliflozin (Farxiga). While their primary action in diabetes is to block glucose reabsorption in the kidneys, they also have cardiovascular and renal benefits that go beyond blood sugar control.

For heart failure patients, diabetic or not, SGLT2 inhibitors:

  • Reduce preload and afterload by promoting mild diuresis (removing extra fluid without drastically lowering blood pressure).
  • Improve vascular function and reduce inflammation.
  • Enhance cardiac energy efficiency by shifting metabolism toward ketone use.
  • Protect the kidneys, which is critical in heart failure management.

These mechanisms are thought to reduce hospitalization risk and improve symptoms and quality of life.

Clinical Evidence Supporting Use in Non-Diabetic Patients

Several major trials have shifted how doctors think about SGLT2 inhibitors:

1. DAPA-HF Trial – Showed dapagliflozin reduced cardiovascular death or worsening HF by 26% in patients with heart failure with reduced ejection fraction (HFrEF), regardless of diabetes status.

2. EMPEROR-Reduced Trial – Empagliflozin showed similar benefits in HFrEF patients, again independent of diabetes status.

3. EMPEROR-Preserved Trial – The first trial to demonstrate benefit in heart failure with preserved ejection fraction (HFpEF), a group with historically few effective therapies.

Together, these trials led to AHA/ACC/HFSA guideline updates recommending SGLT2 inhibitors for nearly all patients with heart failure, regardless of whether they have type 2 diabetes.

using farxiga for heart failure without diabetes

Shop Farxiga for $109

Buy Now

Cost and Access: U.S. vs. Canadian Pricing

In the U.S., brand-name Jardiance and Farxiga can cost $500+ per month without insurance. For patients paying out of pocket, this can be a barrier to long-term therapy.

Some Americans choose to order from licensed Canadian pharmacies or prescription referral services, where medications are Health Canada–approved and often much cheaper.

MedicationU.S. Retail (30 tablets)Canadian Price (30 tablets)
Jardiance 10 mg~$570$109
Jardiance 25 mg~$580$125
Farxiga 5 mg~$560$112

Patients considering this option should still have their prescriptions managed by a U.S. doctor for safety and monitoring.

heart failure medications from canada

Safety Considerations in Non-Diabetic Patients

While SGLT2 inhibitors are generally well-tolerated, non-diabetic patients should be aware of possible side effects:

  • Urinary tract or genital yeast infections (due to higher urinary glucose).
  • Dehydration or low blood pressure, especially if combined with strong diuretics.
  • Rare risk of ketoacidosis, even in non-diabetics, though much less common.

Most side effects can be managed with proper hydration and monitoring, and benefits typically outweigh risks.

The Future of SGLT2 Inhibitors in Heart Failure Care

SGLT2 inhibitors have transformed heart failure management. For non-diabetic patients, they are no longer considered “off-label” but are now a core part of treatment, improving survival and reducing hospitalization.

Ongoing research is exploring their role in earlier stages of heart failure and in combination with other emerging therapies, meaning their importance is likely to grow.

FAQ

Can SGLT2 inhibitors be used if I don’t have diabetes?
Yes. Major clinical trials have proven benefit in heart failure patients regardless of diabetes status, and guidelines now recommend their use for many non-diabetic patients.

Are Jardiance and Farxiga the same?
Both are SGLT2 inhibitors with similar benefits for heart failure, but they are different drugs and may have slight differences in dosing and insurance coverage.

Will SGLT2 inhibitors replace my other heart medications?
No, they are used alongside other heart failure medications, not as a replacement.

What if I can’t afford them in the U.S.?
Some patients find lower prices by ordering through licensed Canadian sources. Always work with your healthcare provider to ensure safe and legal access.

Do I need frequent lab work when on these medications?
Your doctor will likely check kidney function and electrolytes regularly, especially in the first few months.

Disclaimer: This article is for informational purposes only and not medical advice. Consult a licensed healthcare provider before starting or changing medications. Use reputable, licensed pharmacies to ensure safety.